Machine Learning Tool for New Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitors. [PDF]
Łapińska N+3 more
europepmc +1 more source
The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis. [PDF]
Kamp CB+10 more
europepmc +1 more source
Antidepressant use and cognitive decline in patients with dementia: a national cohort study. [PDF]
Mo M+11 more
europepmc +1 more source
Efficacy of non-invasive brain stimulation combined with antidepressant medications for depression: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Tao Y+5 more
europepmc +1 more source
Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder. [PDF]
Jarčušková D+9 more
europepmc +1 more source
Psychiatric comorbidities and prescribing tendencies of sleep medications and related medications in young people with insomnia: a United States commercial claims-based analysis. [PDF]
Bushnell G+7 more
europepmc +1 more source
Reactivity of Olanzapine and Tricyclic Antidepressants on the Protective Effects of Trolox on Lipid Peroxidation Evaluated Using Fluorescence Anisotropy, Electron Paramagnetic Resonance Spectrometry, and Thermal Analysis. [PDF]
Horizumi Y+5 more
europepmc +1 more source
Associations of medical outcomes with substances involved in suicide attempt cases age 50 and older reported to U.S. Poison Centers, 2016-2023. [PDF]
Choi NG, Choi BY, Marti CN, Baker SD.
europepmc +1 more source
Lumateperone for the Treatment of Major Depressive Disorder With Mixed Features or Bipolar Depression With Mixed Features: A Randomized Placebo-Controlled Trial. [PDF]
Durgam S+7 more
europepmc +1 more source
Pharmacogenomic scores in psychiatry: systematic review of current evidence. [PDF]
Sharew NT+3 more
europepmc +1 more source